Cronos (CRON) Depreciation & Amortization (CF) (2019 - 2026)
Cronos (CRON) recorded quarterly Depreciation & Amortization (CF) of $3.7 million in Q1 2026, up 1.91% quarter-over-quarter from $3.7 million in Q4 2025, and up 31.23% on a YoY basis from $2.8 million in Q1 2025.
Cronos (CRON) Depreciation & Amortization (CF) (2019 - 2026) Analysis & Trends
Cronos' Depreciation & Amortization (CF) history runs 8 years deep, the most recent figure standing at $3.7 million for Q1 2026.
- In Q1 2026, Depreciation & Amortization (CF) rose 31.23% year-over-year to $3.7 million; the TTM figure through Mar 2026 stood at $15.1 million (up 44.74% YoY), while the FY2025 annual figure was $14.2 million, up 52.43% from the prior year.
- Depreciation & Amortization (CF) was $3.7 million for Q1 2026 at Cronos, up from $3.7 million in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $4.2 million in Q2 2022 to a low of $1.2 million in Q4 2023.
- Historically, Depreciation & Amortization (CF) has averaged $2.9 million across 5 years, with a median of $2.8 million in 2022.
- The sharpest annual moves came in 2022 and 2025: Depreciation & Amortization (CF) plunged 59.59% in 2022, then surged 177.73% in 2025.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $2.6 million in 2022, then sank by 55.13% to $1.2 million in 2023, then surged by 114.53% to $2.5 million in 2024, then soared by 44.83% to $3.7 million in 2025, then increased by 1.91% to $3.7 million in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $3.7 million (Q1 2026), $3.7 million (Q4 2025), and $3.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 239.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 119.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 22.60 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 7.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 172.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 19.43 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 21.95 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 22.68 Mn |
| 10 | Cronos | 1.06 Bn | 292.44 Mn | 19.15 Mn | 3.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.73 Mn |
| Mar 31, 2026 | 3.73 Mn |
| Dec 31, 2025 | 3.66 Mn |
| Dec 31, 2025 | 3.66 Mn |
| Sep 30, 2025 | 3.53 Mn |
| Sep 30, 2025 | 3.53 Mn |
| Jun 30, 2025 | 4.20 Mn |
| Jun 30, 2025 | 4.20 Mn |
| Mar 31, 2025 | 2.84 Mn |
| Mar 31, 2025 | 2.84 Mn |
| Dec 31, 2024 | 2.53 Mn |
| Dec 31, 2024 | 2.53 Mn |
| Sep 30, 2024 | 3.57 Mn |
| Sep 30, 2024 | 3.57 Mn |
| Jun 30, 2024 | 1.51 Mn |
| Jun 30, 2024 | 1.51 Mn |
| Mar 31, 2024 | 1.73 Mn |
| Mar 31, 2024 | 1.73 Mn |
| Dec 31, 2023 | 1.18 Mn |
| Dec 31, 2023 | 1.18 Mn |